600488 Tianjin Tianyao Pharmaceuticals
- 3.44
- +0.03+0.88%
Tianjin Tianyao Pharmaceuticals News
Announcement of the resolution of the 7th meeting of the 9th Board of Supervisors of Tianjin Tianyao Pharmaceuticals Co., Ltd.
Tianjin Tianyao Pharmaceuticals Co., Ltd. Articles of Association (July 2024)
Announcement of Related Trade between Tianjin Tianyao Pharmaceuticals Co., Ltd. and Tianjin Tianyao Biotechnology Co., Ltd.
Announcement of the Ninth Meeting of the Ninth Board of Directors of Tianjin Tianyao Pharmaceuticals Co., Ltd.
Announcement on the repurchase and cancellation of restricted stocks that have been granted but not yet unlocked under the stock-based incentive plan of Tianjin Tianyao Pharmaceuticals Company Limited, and the adjustment of repurchase price.
Legal opinion from Tianjin Changshi Law Firm on Tianjin Tianyao Pharmaceuticals' repurchase and cancellation of stock-based incentive plan, which has been awarded but not yet unlocked, and adjustment of repurchase price.
Announcement of Tianjin Tianyao Pharmaceuticals Co., Ltd.'s revision of the Company's Articles of Association and completion of business registration changes.
Announcement from Tianjin Tianyao Pharmaceuticals regarding the receipt of approval notification for the listing application of chemical raw materials active pharmaceutical ingredient.
Announcement of Tianjin Tianyao Pharmaceuticals Co., Ltd. regarding the application for loans by pledging its own assets by its subsidiary and related transactions
Announcement of Tianjin Tianyao Pharmaceuticals Co., Ltd. regarding Provision for Asset Impairment
Announcement of the resolution of the sixth meeting of the ninth session of the Board of Supervisors of Tianjin TiaNiao Pharmaceuticals Co., Ltd.
Announcement of the resolution of the 8th meeting of the 9th board of directors of Tianjin Tianyao Pharmaceuticals Co., Ltd.
Announcement of Implementation of Annual Equity Distribution of Tianjin Tianyao Pharmaceuticals Co., Ltd. for the Year 2023
Announcement of Tianjin Pharmaceutical Co., Ltd. on the holding of the 2023 annual results briefing
Announcement of Jinyao Pharmaceutical Co., Ltd. on obtaining the CEP certificate for the active ingredient betamethasone dipropionate
Announcement of Tianjin Pharmaceutical Co., Ltd. on holding the 2023 Annual Results Briefing
Announcement of Tianjin Pharmaceutical Co., Ltd. on preparation for impairment
Announcement of Resolutions of the 7th Meeting of the 9th Board of Directors of Tianjin Pharmaceutical Co., Ltd.
Report for the first quarter of 2024 of Tianjin Pharmaceutical Co., Ltd.
Announcement of Resolutions of the Fifth Meeting of the 9th Board of Supervisors of Tianjin Pharmaceutical Co., Ltd.
Analysis
Price Target
No Data
